4.6 Article

Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2016.04.141

Keywords

Ubiquitin; Innate immunity; TNF; TLR3; NOD1; LUBAC

Funding

  1. Wellcome Trust [WT100294]
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. GlaxoSmithKline
  5. Janssen Pharmaceutica
  6. Merck-Serono
  7. MRC [MC_UU_12016/11, MR/K000985/1] Funding Source: UKRI
  8. Medical Research Council [MC_UU_12016/11, MR/K000985/1] Funding Source: researchfish

Ask authors/readers for more resources

We have reported previously that activation of the MyD88-signaling network rapidly induces the formation of hybrid ubiquitin chains containing both Lys63-linked and Men-linked ubiquitin (Ub) oligomers, some of which are attached covalently to Interleukin Receptor Associated kinase 1. Here we show that Lys63/Metl-Ub hybrids are also formed rapidly when the TNFR1/TRADD, TLR3/TRIF- and NOD1/ RIP2-signaling networks are activated, some of which are attached covalently to Receptor-Interacting Protein 1 (TNFR1 pathway) or Receptor-Interacting Protein 2 (NOD1 pathway). These observations suggest that the formation of Lys63/Met1-Ub hybrids are of general significance for the regulation of innate immune signaling systems, and their potential roles in vivo are discussed. We also report that TNF alpha induces the attachment of Met1-linked Ub chains directly to TNF receptor 1, which do not seem to be attached covalently to Lys63-linked or other types of ubiquitin chain. (C) 2016 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available